ARTICLE

REVIEW DRUG DISSOLUTION AND SOLUBILITY

  1. HOME
  2. ARTICLE

02 Pages : 8-12

http://dx.doi.org/10.31703/giidr.2018(III-I).02      10.31703/giidr.2018(III-I).02      Published : Dec 2018

Review: Drug Dissolution and Solubility

Abstract

    The review's goals are to: a) provide a clear overview of current solubility and dissolution science, b) describe common technologies for assessing solubility and dissolution, and c) recommend the best practice technique. The theories of solubility and dissolution that are required in drug development have been examined, with an emphasis on oral absorption. Dissolution had been elaborated with the equation. Low-water solubility drugs have slow rates of dissolving, which leads to issues with oral bioavailability. Insufficient bioavailability is frequently caused by poorly water-soluble medicines' weak solubility and slow rate of dissolution in aqueous gastrointestinal fluids. Noyes Whitney's equation has been discussed and elaborated in this review. Solubility concepts are revised. Significance points of both dissolution and solubility are related to the oral absorption of drugs.

    Dissolution, Solubility, Oral Drug Delivery

    (1) Najam ul Hassan
    Pharm-D, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
    (2) Maria Naz Bakhtiari
    M.phil, Department of Pharmacy, The Islamia University of Bahawalpur, Punjab, Pakistan.
    (3) Dur E Nayab
    M.phil, Department of Pharmacy, The Islamia University of Bahawalpur, Punjab, Pakistan.
    (4) Gul Shahnaz
    Associate Professor, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan
Fulltext PDF

References

  • Abdou, H. (1989). Theory of dissolution. In: Dissolution, Bioavailability & Bioequivalence. Easton: MACK Publishing Company: 11–36
  • Blanchard, J. (1978). Gastrointestinal absorption II. Formulation factors affecting drug bioavailability. PubMed, 150(5), 132–151. https://pubmed.ncbi.nlm.nih.gov/364993
  • Chen, X., Antman, M., Gesenberg, C., & Gudmundsson, O. (2006). Discovery pharmaceutics—Challenges and opportunities. The AAPS Journal, 8(2), E402–E408. doi.org/10.1007/bf02854912
  • Gibson, M. (2009), Pharmaceutical Pre-formulation and Formulation-A Practical Guide from Candidate Drug Selection to Commercial Dosage Form, 2nd Ed. Informa Healthcare USA Inc., New York, NY 10017:129-170
  • Henck, J., & Byrn, S. R. (2007). Designing a molecular delivery system within a preclinical timeframe. Drug Discovery Today, 12(5–6), 189–199. doi.org/10.1016/j.drudis.2007.01.006
  • Hintz, R. J., & Johnson, K. C. (1989). The effect of particle size distribution on dissolution rate and oral absorption. International Journal of Pharmaceutics, 51(1), 9–17. doi.org/10.1016/0378-5173(89)90069-0
  • Ingels, F., Ungell, A., & Augustijns, P. (2007). Selection of solvent systems for membrane-, cell- and Tissue-Based permeability assessment. In Springer eBooks (pp. 179–220). https://doi.org/10.1007/978-0-387-69154-1_7
  • Kerns, E. H. (2001). High throughput physicochemical profiling for drug discovery. Journal of Pharmaceutical Sciences, 90(11), 1838–1858. doi.org/10.1002/jps.1134
  • Ketan T. Savjani, Anuradha K. Gajjar, and Jignasa K. Savjani (2012). Drug Solubility: Importance and Enhancement Techniques, v.2012, 195727.
  • Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014). Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian Journal of Pharmaceutical Sciences, 9(6), 304–316. doi.org/10.1016/j.ajps.2014.05.005
  • Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249. doi.org/10.1016/s1056-8719(00)00107-6
  • Oberle, R. L., Moore, T. J., & Krummel, D. a. P. (1995). Evaluation of mucosal damage of surfactants in rat jejunum and colon. Journal of Pharmacological and Toxicological Methods, 33(2), 75–81. doi.org/10.1016/1056-8719(94)00060-h
  • Shargel, L., Andrew, B. C. Y (1980). Applied Biopharmaceutics and Pharmacokinetics, 7th edition; chapter 14: 448-488
  • Smith, Blaine Templar (2016). Remington Education: Physical Pharmacy, First Edition, And Chapter 3:31-15

Cite this article

APA

CHICAGO

    CHICAGO : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. 2018. "Review: Drug Dissolution and Solubility." Global Immunological & Infectious Diseases Review, III (I): 8-12 doi: 10.31703/giidr.2018(III-I).02

HARVARD

    HARVARD : HASSAN, N. U., BAKHTIARI, M. N. & NAYAB, D. E. 2018. Review: Drug Dissolution and Solubility. Global Immunological & Infectious Diseases Review, III, 8-12.

MHRA

    MHRA : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. 2018. "Review: Drug Dissolution and Solubility." Global Immunological & Infectious Diseases Review, III: 8-12

MLA

    MLA : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. "Review: Drug Dissolution and Solubility." Global Immunological & Infectious Diseases Review, III.I (2018): 8-12 Print.

OXFORD

    OXFORD : Hassan, Najam ul, Bakhtiari, Maria Naz, and Nayab, Dur E (2018), "Review: Drug Dissolution and Solubility", Global Immunological & Infectious Diseases Review, III (I), 8-12

TURABIAN

    TURABIAN : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. "Review: Drug Dissolution and Solubility." Global Immunological & Infectious Diseases Review III, no. I (2018): 8-12. https://doi.org/10.31703/giidr.2018(III-I).02